Articles by Chitra Sethi - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Chitra Sethi

Chitra Sethi

Managing Editor, BioPharm International

Articles
Spectrum Pharmaceuticals to Develop Biosimilar Rituximab
January 13, 2011

California-based biopharmceutical company Spectrum Pharmaceuticals will develop a biosimilar version of Swiss pharmaceutical giant Roche Holding AG's monoclonal antibody drug rituximab. Spectrum aims to achieve this through a partnership with Viropro Inc (Irvine, CA).

BioPharm International's 5th Annual Empolyment Survey
January 1, 2011

How did biopharmaceutical professionals fare during a year of hiring freezes, high anxiety, and increased workload? Our survey finds out.

ATMI Acquires Artelis to Expand Portfolio of Single-Use Technology Products
November 4, 2010

ATMI, Inc. has acquired the Belgian biotechnology firm Artelis SA, which offers technologies for cell culture research and manufacturing scale-up.

Gilead Sciences Receives FDA Warning Letter
October 14, 2010

On September 21, 2010, Gilead Sciences (San Dimas, CA) received a warning letter from the US Food and Drug Administration, citing violations of current good manufacturing practices (cGMP) for its manufacturing and quality processes related to the production of antifungal agent AmBisome at its California facility.

Genzyme and Sanofi Slash Workforces
September 16, 2010

Genzyme and Sanofi cut jobs.

Shire Gains European Approval for its Gaucher Disease Treatment
August 27, 2010

Shire has gained European approval for its gaucher disease treatment

EMA and FDA Seek Applicants for Joint GMP Inspections
August 19, 2010

EMa and FDA are seeking potential candidate companies for a joint GMP inspection pilot program.

ATMI Expands Bloomington, Minnesota Manufacturing Facility
August 3, 2010

ATMI Inc. has established a North American hub for the production, marketing, and development of its single-use technologies for biopharmaceutical and other life sciences applications by expanding its Bloomington, MN manufacturing facility.

Hospira to Handle Fill-Finish Operations for Genzyme's Multiple Drugs
July 8, 2010

Genzyme has signed a new supply agreement with Hospira Inc

ADVERTISEMENT

ADVERTISEMENT

Click here